4
Changes in Ownership
Tempest Therapeutics, Inc. Filed Acc 0001209191-20-006355
Options or other derivatives
- Chief Development Officer acquired 41,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Zeidan Ryan Chief Development Officer | 2020-01-31 | Grant or award · Employee Stock Option (right to buy) | +41,250 | 41,250 | D | ||
Loading xslF345X03/doc4.xml…